29.7 percent of those aged 60 years or older reported primary prevention use in 2021, with 5.2 percent using without medical advice
Childhood Risk Factors Directly Tied to Adult Cardiovascular Disease
Largest direct effect seen for childhood BMI and low-density lipoprotein cholesterol
FDA Expands Approval for Duchenne Muscular Dystrophy Gene Therapy
Approval allows for use in nonambulatory individuals ≥4 years with a confirmed gene mutation
Vigorous Physical Activity May Preserve Cognitive Function in High-Risk HTN
High versus low VPA linked to lower risk of MCI, probable dementia, MCI/probable dementia in multivariate model
NT-proBNP, IL-1RL Can Identify High-Risk Congenital Heart Disease in Neonates
Combining NT-proBNP and IL-1 RL1 tests performed well, enabling additional identification of asymptomatic babies
Triglyceride-Glucose Index Independently Linked to All-Cause Mortality
Association with in-hospital and one-year mortality seen for patients with heart failure and chronic kidney disease
Fewer Adults Eligible for Statins With PREVENT Equations
Most adults eligible for statins based on PREVENT equations did not report statin use
Timing of Exercise Significant for Obesity, Metabolic Impairment
Beneficial effect on glucose hemostasis seen for accumulation of more MVPA in the evening for sedentary adults
AI Screens Patients for Clinical Trials With Greater Accuracy Than Staff
In addition to enhanced performance, automated screening cuts costs
Black Patients More Likely to Experience MACE After ADT for Prostate Cancer
Social vulnerability index mediated 98 percent of the disparity in MACE risk between Black and White patients